Societal health and economic burden of cardiovascular diseases in the population with type 2 diabetes in Qatar. A 10 ‐year forecasting model
An erratum to this article was published (Diabetes Obes Metab, Apr 2024 ↗)
Authors' conclusion
The findings suggest a significant economic and health burden of CVD among people with T2D in Qatar and highlight the need for more enhanced preventive strategies targeting this population group.
Study context
- Population
- People with T2D in Qatar aged 40–79 years
- Outcome
- Projected CVD burden in T2D
- Follow-up
- 10 years
Methodological detailsdynamic multistate forecasting model, 10-year forecast, Qatari societal perspective, sensitivity analyses, First cardiovascular disease (CVD) events (myocardial infarction (MI) and stroke) from the 2013 Pooled Cohort Equation; recurrent CVD events from the REACH registry; utility and cost inputs from published sources
- Dynamic multistate forecasting model
- 10-year forecast
- Qatari societal perspective
- Sensitivity analyses
- First CVD events (MI and stroke) from the 2013 Pooled Cohort Equation; recurrent CVD events from the REACH registry; utility and cost inputs from published sources
Main finding
As reported in the abstract
- Non-fatal MIs
- 108 195 (95% UI 104 249-112 172)
- Non-fatal strokes
- 62 366 (95% UI 60 283-65 520)
- CVD deaths
- 14 612 (95% UI 14 472-14 744)
- Total years of life lived
- 4 786 605 (95% UI 4 743 454, 4 858 705)
- Total quality-adjusted life years
- 3 781 833 (95% UI 3 724 718-3 830 669)
- Direct costs (57.85% of total costs)
- QAR41.60 billion (US$11.40 billion) (95% UI 7.53-147.40 billion (US$2.06-40.38 billion))
- Total indirect costs, expected to exceed
- QAR30.31 billion (US$8.30 billion) (95% UI 1.07-162.60 billion (US$292.05 million-44.55 billion))
Original publication
Societal health and economic burden of cardiovascular diseases in the population with type 2 diabetes in Qatar. A 10 ‐year forecasting model. Diabetes Obes Metab. Published 16 October 2023. doi:10. 1111/ dom. 15299
Composed by AI from the published abstract and checked against it. How Briefs are made →